NOT-AG-24-014: Notice of Change to Letter of Intent Due Date(s) Information Listed in RFA-AG-24-001, Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)

Notice of Change to Letter of Intent Due Date(s) Information Listed in RFA-AG-24-001, “Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)”

Notice Number:

NOT-AG-24-014

Key Dates

Release Date:

March 28, 2024

Related Announcements

January 12, 2023 - “Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)”. See NOFO RFA-AG-24-001.

Issued by

National Institute on Aging (NIA)

Purpose

This Notice informs potential applicants that the Letter of Intent Due Date(s) information listed in RFA-AG-24-001, “Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)” was amended to account for all listed Application Due Dates.

The following section under Part 1. Overview Information of RFA-AG-24-001 was modified as follows:

Key Dates

Previously Read: Letter of Intent Due Date(s): May 14, 2023

Revised to Read: Letter of Intent Due Date(s): 30 days before each application due date

All other aspects of the NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Cerise Elliott, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9350
Email: [email protected]

Nina B. Silverberg, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9350
Email: [email protected]